Search
for
Sort by
Research 61–90 of 742
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Does a male polycystic ovarian syndrome equivalent exist?
- Effect of finasteride in idiopathic hirsutism
- Androgen receptor gene CAG and GGN polymorphisms in infertile Nigerian men
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Cross-sex hormone therapy for gender dysphoria
- A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism
- Alterations of gut microbiota composition in post-finasteride patients: a pilot study
- Role of vitamin D and calcium signaling in epidermal wound healing
- Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
- Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance.
- Lack of endocrine systemic side effects after topical application of spironolactone in man
- 5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia
- How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
- Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men
- Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome
- Maternal androgen excess inhibits fetal cardiomyocytes proliferation through RB-mediated cell cycle arrest and induces cardiac hypertrophy in adulthood
- Androgenic alopecia in a postmenopausal Sicilian baroness
- GH-IGF-I axis in non-obese women with functional hyperandrogenism
- “Who and how to screen for endogenous hypercortisolism among young women presenting with clinical hyperandrogenism and/or menstrual abnormalities ”
- Endo&Art why Diana is depicted with mild androgenic alopecia?
- Efficacy of topical minoxidil in enhancing beard growth in a group of transgender assigned female at birth individuals on gender affirming hormone therapy
- Analysis of the finasteride treatment and its withdrawal in the rat hypothalamus and hippocampus at whole-transcriptome level
- Diabetes, ovarian tumor, hyperparathyroidism, and papillary cancer: A chance association?
- Lifestyle and Physiological Factors Associated with Facial Wrinkling in Men and Women
- Síndrome de ovario poliquístico: la distancia anogenital como marcador del entorno androgénico prenatal y revisión y comparación de los criterios diagnósticos
- Dermal White Adipose Tissue: A Newly Recognized Layer of Skin Innate Defense
- Exploring the “Thyroid–Skin Connection”: Concepts, Questions, and Clinical Relevance